These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3278672)

  • 1. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group.
    Ann Neurol; 1990 Jun; 27(6):591-605. PubMed ID: 2193613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine versus azathioprine in the treatment of multiple sclerosis: 12-month clinical and immunological evaluation.
    Steck AJ; Regli F; Ochsner F; Gauthier G
    Eur Neurol; 1990; 30(4):224-8. PubMed ID: 2209678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical trial of cyclosporine in multiple sclerosis: the pros.
    Dommasch D
    Neurology; 1988 Jul; 38(7 Suppl 2):28-9. PubMed ID: 3290711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study.
    Fernández O; Guerrero M; Mayorga C; Muñoz L; Leán A; Luque G; Hervás M; Fernández V; Capdevila A; de Ramón E
    J Neurol; 2002 Aug; 249(8):1058-62. PubMed ID: 12195454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis.
    Woessner R; Grauer MT; Frese A; Bethke F; Ginger T; Hans A; Treib J
    Infection; 2006 Dec; 34(6):342-4. PubMed ID: 17180590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine and multiple sclerosis: the cons.
    Rudge P
    Neurology; 1988 Jul; 38(7 Suppl 2):29-30. PubMed ID: 3290712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
    Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot-study on large-dose alternate-day steroid therapy in multiple sclerosis.
    Cendrowski WS
    Schweiz Arch Neurol Neurochir Psychiatr; 1975; 117(2):197-203. PubMed ID: 1224185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.